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Abstract
RNA silencing plays an important role in development through the action of microRNAs, which fine
tune the expression of a large portion of the genome. It is also very important in innate immune
responses, especially in antiviral and antibacterial defenses in plants, insects, and animals. Two recent
papers now indicate that apicomplexan parasites display the ability to interfere with host microRNA
populations.
Introduction and context
The phylum Apicomplexa includes a large group of
protozoan parasites responsible for a wide range of
animal and human diseases. Among the human patho-
gens are Plasmodium falciparum and Plasmodium vivax, the
major causative agents of human malaria, as well as
Cryptosporidium parvum and Toxoplasma gondii, which are
particularly pathogenic in immunocompromised
patients. Apicomplexa are intracellular obligatory para-
sites that multiply in a so-called parasitophorous
vacuole. Although the alterations of the host cell
harboring Toxoplasma or Plasmodium parasites have
been extensively documented at the cellular level, still
little is known about how the parasite manipulates the
host cell at the molecular level, with the notable
exception of Plasmodium infection of host erythrocytes.
So far, most molecular studies on the host-parasite
interface have focused on the role of parasite factors that
are secreted by the invading parasite, as well as by the
resident intracellular parasite, into the host cell [1,2].
These intracellular parasites are expected to profoundly
reorganize the host cell for their own needs to ensure safe
growth and persistence, and presumably to deploy the
most sophisticated mechanisms to this end.
Emerging evidence indicates that viruses and bacteria
manipulate the microRNA (miRNA) pathways of the host
cells they infect. miRNAs are the most abundant class of
small,non-coding, single-stranded RNAs and are involved
in regulating gene expression at the post-transcriptional
level [3]. In silico target prediction suggests that miRNAs
may control up to 30% of the translation of the human
transcriptome [4]. As such, they govern a variety of
fundamental cell functions, including cell proliferation
and apoptosis, and are key regulators of cell metabolism.
When homeostatic conditions are disrupted – for
example, when cells encounter micro-organisms – these
regulatory pathways might also contribute to host cell
responses/defenses (i.e., the inflammatory response)
against the foreign bodies [5]. For example, cell infection
by mammalian viruses might be counteracted by cellular
miRNAs that target either the virus itself, as in the case of
the rhabdoviral vesicular stomatitis virus, or a host factor
critical to the virus, as for the lentiviral HIV. Conversely,
miRNAs can also act in favor of the micro-organism,
either when it is pathogen-encoded (e.g., mammalian
virus-encoded miRNAs) or when the micro-organism
subverts host miRNAs to its own benefit [6]. Effectors
from the bacteria Pseudomonas syringae have been recently
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miRNAs generated upon sensing of PAMPs (pathogen-
associated molecular patterns) by Arabidopsis [7].
Major recent advances
Recent data have begun to show how two apicomplexan
parasites, Cryptosporidium and Toxoplasma, are able to
target miRNAs in the host cell to alter the cellular
environment in ways that favor their intracellular
development. Cryptosporidium is able to trigger the
down-regulation of let-7i (a miRNA with complemen-
tarity to Toll-like receptor (TLR)-4 mRNA) in the host
cell, leading to the up-regulation of TLR4, a key pathogen
recognition molecule that plays a central role in
epithelial innate immunity to Cryptosporidium infection
[8]. Various studies have further substantiated the ability
of Cryptosporidium to alter miRNA expression in cholan-
giocytes [9-11]. It is emerging from these studies that
following Cryptosporidium infection, specific miRNA
cluster genes are activated by the binding of the NF-kB
(nuclear factor-kappa B) p65 subunit to their promoter,
and that inhibition of these miRNAs increases parasite
burden [11]. These results mirror those showing differ-
ential alterations in mature miRNA expression profiles
in primary human fibroblast cells following Toxoplasma
infection [12]. Zeiner et al. [12] showed that Toxoplasma
infection specifically increased the transcription of the
miR-17/92 loci by two- to three-fold in human fibro-
blasts. The effect is apparently a specific response to
Toxoplasma infection since levels of the mature miR-17/
92-derived miRNAs remained unchanged upon infection
by the closely related parasite Neospora caninum [12].
Microarray data comparing the miRNA profiles of cells
infected by Toxoplasma or Cryptosporidium or treated with
lipopolysaccharide (LPS) have revealed several impor-
tant findings. For example, miR-155/BIC is up-regulated
upon Toxoplasma infection but remains unaffected or is
down-regulated when exposed to Cryptosporidium or LPS,
respectively [11]. Ofnote, miR-155hasanimportant role
in the mammalian immune system, regulating, at least in
part, cytokine production [13]. Two other miRNAs, miR-
198 and miR-320, are both up-regulated upon Toxo-
plasma infection whereas they are down-regulated after
Cryptosporidium infection and unaffected after LPS stimu-
lation [11,12]. These data point to specific modifications
of host miRNA profiles upon cell infection by Apicom-
plexa parasites. Obviously, any change in the host cell
miRNA pattern might indicate either a defense mechan-
ism by the cell or a subversion strategy by the parasite,
two processes that can be differentiated by evaluating the
consequences on parasite growth of disruption or over-
expression of the target miRNA pathway.
Future directions
Given the propensity of apicomplexan parasites to co-
opt cellular pathways and activities for their benefit, it is
perhaps not surprising that these parasites could also
reshape their cellular environment by reprogramming
the host’s RNA interference machinery. Specific host
miRNAs could either counteract the intracellular growth
of parasites or facilitate it, the two possibilities being not
mutually exclusive and depending on the physiological
context. These findings open an exciting opportunity to
pursue a deep understanding of how the host proteome
can be reprogrammed dynamically and reversibly upon
Apicomplexa infection.
An additional line of research should explore the
upstream regulatory mechanisms, that is, how the
parasites directly interfere with RNA silencing pathways
and, more specifically, the parasite effectors that are
involved in the process. As discussed above, in response
to Cryptosporidium and Toxoplasma infections, the expres-
sion of specific miRNA genes is altered at the transcrip-
tional level [11,12]. miRNA are generated through the
concerted action of multi-subunit complexes that pro-
mote the sequential cleavage, export, and loading of
miRNA into silencing complexes. An increasing number
of reports suggest that, beyond the transcriptional
control of genes that code cluster miRNAs, each of
these steps serves as a potential point of regulation, and
therefore adds additional complexity to miRNA-depen-
dent gene regulation [3,14,15].
Could parasite regulators of host miRNAS be ribonucleic
acids? Unlike in Cryptosporidium and Plasmodium species,
the Toxoplasma genome encodes elaborate RNA silencing
machinery that generates endogenous small silencing
RNAs, including specific miRNAs [16]. Thus, an attractive
hypothesis is that Toxoplasma has the potential to secrete
its own miRNAs to hijack the host cell miRNA defense
pathway, similar to what some viruses are able to do.
Effectors may also be parasite proteins. It is known that
apicomplexan parasites inject various molecules into the
host cell resulting in extensive remodeling of the host cell
gene expression profile and metabolic pathways [17-19].
The expression of host miRNAs can also be altered in
response to parasite recognition by cell surface TLRs [20].
Both intrinsic and extrinsic acting factors could then
interfere with target host miRNAs, at any point of the
processing of the pri-miRNAs and biogenesis of the
miRNAs – transcription, processing, or export.
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